AbbVie Inc. (ABBV)
After hours:
| Previous close | 167.29 |
| Open | 167.09 |
| Bid | 159.73 x 800 |
| Ask | 159.76 x 800 |
| Day's range | 157.66 - 167.46 |
| 52-week range | 130.96 - 182.89 |
| Volume | |
| Avg. volume | 5,630,903 |
| Market cap | 282.631B |
| Beta (5Y monthly) | 0.56 |
| PE ratio (TTM) | 58.47 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 6.20 (3.71%) |
| Ex-dividend date | 12 Apr 2024 |
| 1y target est | N/A |
- Yahoo Finance Video
Microsoft, Alphabet earnings fuel stock rally: Yahoo Finance
All three of the major indexes (^DJI,^GSPC, ^IXIC) are jumping on better-than-expected quarterly results from Alphabet (GOOG, GOOGL) and Microsoft (MSFT). The earnings are providing evidence to investors that artificial intelligence is more than hype; there is a lot of cash being spent on the tech. Wall Street is also digesting another inflation report. The core March Personal Consumption Expenditures reading was slightly hotter than expected, but not enough to deter expectations that the Federal Reserve will eventually cut rates. Trending tickers on Yahoo Finance include Intel (INTC), Snap (SNAP), AbbVie (ABBV). Top guests today include: 3:15 p.m. ET - Daniel Yergin, S&P Global Vice Chairman 3:45 p.m. ET - Peter Arment, Baird Senior Analyst and Tony Bancroft, Gabelli Funds Portfolio Manager 4:25 p.m. ET - Robert D'Loren, Xcel CEO 4:35 p.m. ET - Mike Brown, Travel + Leisure CEO
- Investor's Business Daily
AbbVie Is 'Firing On All Cylinders,' But Its Stock Doesn't Show That
AbbVie is "firing on all cylinders," an analyst said Friday after the firm beat first-quarter estimates. But AbbVie stock fell.
- Zacks
AbbVie (ABBV) Beats on Q1 Earnings & Sales, Ups '24 EPS View
AbbVie's (ABBV) first-quarter earnings and sales beat estimates. Management hikes the EPS guidance on the back of encouraging Skyrizi product sales.
